The Patent Finder
MI

MicroVention, Inc.

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

265 patents currently held

32 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Jun 2027. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
26
Ending by 2030
Jun 2027
Next term end
108
Patent families

When these terms end

Held patents by the year their term ends
notable patents fee due within 90 days all others Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Filamentary Devices for Treatment of Vascular Defects US 11,723,667
Cited by 25 later US patents, top 5% of utility patents granted in 2023 in our data. Protection runs to 2034. A terminal disclaimer caps this term to an earlier patent's.
Ends Aug 2034 · High confidence
Also notable
Methods and Devices for Treatment of Vascular Defects US 11,179,159
Cited by 55 later US patents, top 5% of utility patents granted in 2021 in our data. Protection runs to 2028.
Ends Dec 2028 · High confidence
Also notable
Polymeric Treatment Compositions US 9,937,201
Cited by 90 later US patents, top 5% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2033.
Ends Jun 2033 · High confidence

Formerly held, still cited

Notable
Cited by 296 later US patents, top 1% of utility patents granted in 2019 in our data. Protection runs to 2037.
now held by Terumo Corporation
Ends Sep 2037 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 11 fees due Jan 4 to 28, 2027 · next Jan 4
  • 9 fees due Feb 1 to 28, 2027 · next Feb 1
  • 4 fees due Mar 5 to 19, 2027 · next Mar 5
  • 1 fee due Apr 30, 2027
    The maintenance fee for Polymeric Treatment Compositions (US 11,801,326) comes due Apr 30, 2027. Unpaid by Nov 1, 2027, it lapses early.
  • 2 fees due May 7 to 28, 2027 · next May 7
  • 4 fees due Jun 1 to 30, 2027 · next Jun 1
  • 9 fees due Jul 2 to 30, 2027 · next Jul 2
  • 6 fees due Aug 6 to 27, 2027 · next Aug 6
  • 7 fees due Sep 3 to 29, 2027 · next Sep 3
  • 4 fees due Oct 2 to 14, 2027 · next Oct 2
  • 3 fees due Nov 5 to 7, 2027 · next Nov 5

Which patents, and when each one lapses · Pro

Recent changes

  • 5 of the patents on this record were granted since Aug 23, 2026
  • 7 terms have ended since Aug 23, 2026

What they patent

The largest of its 108 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Braiding Mechanism and Methods of Use13 in forceto May 2032
Filamentary Devices for Treatment of Vascular Defects11 in forceto Feb 2035
Delivery and Detachment Systems and Methods for Vascular Implants10 in forceto May 2039
Embolization Device Constructed from Expansile Polymer9 in forceto Jun 2029
Particles8 in forceto Mar 2036

Patents held now

Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 9,451,963Embolization Device Constructed From Expansile Polymer
In force
 · High confidence
In forceHigh confidence
US 9,724,103Embolization Device Constructed from Expansile Polymer
In force
 · High confidence
In forceHigh confidence
US 9,877,731Embolization Device Constructed From Expansile Polymer
In force
 · High confidence
In forceHigh confidence
US 10,226,258Embolization Device Constructed from Expansile Polymer
In force
 · High confidence
In forceHigh confidence
US 10,499,925Embolization Device Constructed From Expansile Polymer
In force
 · High confidence
In forceHigh confidence
US 11,160,557Embolization Device Constructed from Expansile Polymer
In force
 · High confidence
In forceHigh confidence
US 11,185,336Embolization Device Constructed From Expansile Polymer
In force
 · High confidence
In forceHigh confidence
US 11,707,281Thermal Detachment System For Implantable Devices
In force
 · Low confidence
In forceLow confidence
US 9,259,228Embolization Device Constructed from Expansile Polymer
In force
 · High confidence
In forceHigh confidence
US 9,259,337Methods and Devices for Treatment of Vascular Defects
In force
 · Medium confidence
In forceMedium confidence
10 of 265 patents shown.
Pro members see all 265.
Pro members: see all 265 patents
Also on record, not counted in the 265: 32 patents in force now held by others · 28 patents ended · 114 applications pending · 52 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited